RAZ
0
R
PRISM
Explore
Companies
Frontier
Ledger
Method
Workbench
live
←
All collisions
Field dossier · from the corpus
Etoposide
0
predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
2019
2,284 citations
DOI ↗